Centralized data and specimen repository for COVID-19 at Duke
Duke Shared Data and Specimen Repository Regarding COVID-19 Patients
Duke University · NCT04368234
This study is setting up a secure place to collect and store important COVID-19 data and samples from patients at Duke University to make research easier and less repetitive for everyone involved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Sex | All |
| Sponsor | Duke University (other) |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT04368234 on ClinicalTrials.gov |
What this trial studies
This project aims to create a secure and centralized repository for collecting essential data and medical specimens related to COVID-19 at Duke University. It will store core variables of interest that align with those agreed upon by Academic Medical Centers across the U.S., facilitating efficient de-identified data reuse for population-level research. By centralizing data storage, the project aims to reduce the burden on subjects by minimizing repetitive data collection across different studies. The repository will include data from patients with confirmed or suspected COVID-19 and will house individual consent forms for all participating studies.
Who should consider this trial
Good fit: Ideal candidates include individuals with suspected or confirmed COVID-19 infections who are participating in any COVID-related studies at Duke.
Not a fit: Patients who are not involved in any COVID-related studies or do not meet the inclusion criteria for the repository may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this repository could streamline COVID-19 research and improve the efficiency of data collection and analysis.
How similar studies have performed: Other studies have successfully implemented similar data repositories for COVID-19, indicating a promising approach for research.
Eligibility criteria
Show full inclusion / exclusion criteria
Subjects will be included in this data repository if they meet the enrollment criteria of any linked/participating IRB-approved protocol, or if they are not enrolled in another COVID-related study but meet one of the following inclusion criteria: 1. Suspected novel Coronavirus (nCoV) infection (Person Under Investigation) and/or 2. Laboratory proven acute novel Coronavirus (nCoV) infection and/or 3. Primary admitting diagnosis of nCoV infection Studies will include: * Any COVID-19 clinical research studies recruiting Duke patients * Excludes: protocols sharing non-consented EHR data with national/international repositories and studies that are recruiting community participants
Where this trial is running
Durham, North Carolina
- Duke University Medical Center — Durham, North Carolina, United States (RECRUITING)
Study contacts
- Principal investigator: Chris Woods, MD — Duke University
- Study coordinator: Lynn Sutton
- Email: lynn.sutton@duke.edu
- Phone: 919-668-8925
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COVID-19, Data Specimen Repository